Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth M Jaffee

Showing results (121-130 of 291) with videos related to

Pageof 30
Sort By:
Cancer Research|November 9, 2016
Heterogeneous Stromal Signaling within the Tumor Microenvironment Controls the Metastasis of Pancreatic CancerAgnieszka A Rucki, Kelly Foley, Pingbo Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2007
A vascular endothelial growth factor receptor-2 inhibitor enhances antitumor immunity through an immune-based mechanismElizabeth A Manning, John G M Ullman, James M Leatherman, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 16, 2020
Inhibition of miR-21 Regulates Mutant KRAS Effector Pathways and Intercepts Pancreatic Ductal Adenocarcinoma DevelopmentNina J Chu, Robert A Anders, Elana J Fertig, et al.
Translational Oncology|April 13, 2012
Development of a novel preclinical pancreatic cancer research model: bioluminescence image-guided focal irradiation and tumor monitoring of orthotopic xenograftsRichard Tuli, Andrew Surmak, Juvenal Reyes, et al.
Briefings in Bioinformatics|August 23, 2024
Computational methods and biomarker discovery strategies for spatial proteomics: a review in immuno-oncologyHaoyang Mi, Shamilene Sivagnanam, Won Jin Ho, et al.
Gastroenterology|June 5, 2019
Axon Guidance Molecules Promote Perineural Invasion and Metastasis of Orthotopic Pancreatic Tumors in MiceNoelle R Jurcak, Agnieszka A Rucki, Stephen Muth, et al.
Cancer Immunology Research|May 3, 2019
Programmed Cell Death Ligand-1 (PD-L1) and CD8 Expression Profiling Identify an Immunologic Subtype of Pancreatic Ductal Adenocarcinomas with Favorable SurvivalLudmila Danilova, Won Jin Ho, Qingfeng Zhu, et al.
Cancer Immunology Research|May 10, 2017
A STING Agonist Given with OX40 Receptor and PD-L1 Modulators Primes Immunity and Reduces Tumor Growth in Tolerized MiceJeremy B Foote, Marleen Kok, James M Leatherman, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Modeling cellular influence delineates functionally relevant cellular neighborhoods in primary and metastatic pancreatic ductal adenocarcinomaYeonju Cho, Jae W Lee, Sarah M Shin, et al.
JCI Insight|May 22, 2020
Effects of B cell-activating factor on tumor immunityMark Yarchoan, Won Jin Ho, Aditya Mohan, et al.
Pageof 30

Showing results (121-130 of 291) with videos related to

Sort By:
Pageof 30
Cancer Research|November 9, 2016
Heterogeneous Stromal Signaling within the Tumor Microenvironment Controls the Metastasis of Pancreatic CancerAgnieszka A Rucki, Kelly Foley, Pingbo Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2007
A vascular endothelial growth factor receptor-2 inhibitor enhances antitumor immunity through an immune-based mechanismElizabeth A Manning, John G M Ullman, James M Leatherman, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 16, 2020
Inhibition of miR-21 Regulates Mutant KRAS Effector Pathways and Intercepts Pancreatic Ductal Adenocarcinoma DevelopmentNina J Chu, Robert A Anders, Elana J Fertig, et al.
Translational Oncology|April 13, 2012
Development of a novel preclinical pancreatic cancer research model: bioluminescence image-guided focal irradiation and tumor monitoring of orthotopic xenograftsRichard Tuli, Andrew Surmak, Juvenal Reyes, et al.
Briefings in Bioinformatics|August 23, 2024
Computational methods and biomarker discovery strategies for spatial proteomics: a review in immuno-oncologyHaoyang Mi, Shamilene Sivagnanam, Won Jin Ho, et al.
Gastroenterology|June 5, 2019
Axon Guidance Molecules Promote Perineural Invasion and Metastasis of Orthotopic Pancreatic Tumors in MiceNoelle R Jurcak, Agnieszka A Rucki, Stephen Muth, et al.
Cancer Immunology Research|May 3, 2019
Programmed Cell Death Ligand-1 (PD-L1) and CD8 Expression Profiling Identify an Immunologic Subtype of Pancreatic Ductal Adenocarcinomas with Favorable SurvivalLudmila Danilova, Won Jin Ho, Qingfeng Zhu, et al.
Cancer Immunology Research|May 10, 2017
A STING Agonist Given with OX40 Receptor and PD-L1 Modulators Primes Immunity and Reduces Tumor Growth in Tolerized MiceJeremy B Foote, Marleen Kok, James M Leatherman, et al.
Biorxiv : the Preprint Server for Biology|July 16, 2025
Modeling cellular influence delineates functionally relevant cellular neighborhoods in primary and metastatic pancreatic ductal adenocarcinomaYeonju Cho, Jae W Lee, Sarah M Shin, et al.
JCI Insight|May 22, 2020
Effects of B cell-activating factor on tumor immunityMark Yarchoan, Won Jin Ho, Aditya Mohan, et al.
Pageof 30